The relationship of interacting immunological components in dengue pathogenesis

Virology Journal

Volumn 6, Issue , 2009, Pages

  Nielsen, David G ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; CD209 ANTIGEN; CD8 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 3; NON STRUCTURAL PROTEIN 1 ANTIBODY; NONSTRUCTURAL PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ANTIBODY; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CYTOKINE; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; CHILDHOOD MORTALITY; CLINICAL FEATURE; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; EFFECTOR CELL; HEMORRHAGIC FEVER; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; VIRUS PATHOGENESIS; ANTIBODY DEPENDENT ENHANCEMENT; BLOOD; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; SECRETION; SHOCK; T LYMPHOCYTE;

ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; CELL ADHESION MOLECULES; CYTOKINES; DENDRITIC CELLS; DENGUE; DENGUE VIRUS; HUMANS; LECTINS, C-TYPE; RECEPTORS, CELL SURFACE; SHOCK; T-LYMPHOCYTES;

EID: 72849114476     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-211     Document Type: Review

References (52)

1. World Health Organization. Impact of Dengue, http://www.who.int/csr/ disease/dengue/impact/en/index.html
2. Dengue, Dengue haemorrhagic fever and Dengue shock syndrome in the context of the Integrated Management of Childhood Illness. http://www.who.int/ child-adolescent-health/documents/fch-cah-05-13/en/index.html
3. Dengue fever - eMedicine Emergency Medicine. http://emedicine.medscape. com/article/781961-overview
4. Dengue DHS/DSS. http://www.whoindia.org/cds/DiseaseSurveillance/IDSP/ WHO%20 Manual/vol2/DENGUE.pdf
5. "Understanding the contribution of cellular immunity to dengue disease pathogensis". A Mathew A Rothman, Immunoulogical Reviews 2008 225 300 313 10.1111/j.1600-065X.2008.00678.x
6. "Neutralization and Antibody-Dependent Enhancement of Dengue Viruses". S Halstead, Advances in Virus Research 2003 60 421 467 full-text 14689700
7. "Monoclonal antibody-mediated enhancement of Dengue virus infection in vitro and in vivo and strategies for prevention". A Goncalvez R Engle M St. Claire R Purcell C Lai, Proceedings of the National Academy of Sciences in the United States of America 2007 104 22 9422 9427 10.1073/pnas.0703498104 (Pubitemid 47185795)
8. "Monoclonal antibody-mediated enhancement of Dengue virus infection in vitro and in vivo and strategies for prevention". A Goncalvez R Engle M St Claire R Purcell C Lai, Proceedings from the National Academy of Science USA 2007 104 9422 9427 10.1073/pnas.0703498104 (Pubitemid 47185795)
9. "Dengue". S Halstead, Lancet 2007 370 1644 52 10.1016/S0140-6736(07)61687-0 17993365
10. Dengue hemorrhagic fever in infants: research opportunities ignored. SB Halstead NT Lan TT Myint TN Shwe A Nisalak S Kalyanarooj S Nimmannitya S Soegijanto DW Vaughn TP Endy, Emerging Infectious Disease 2002 8 1474 1479
11. "Role of antibodies in controlling dengue virus infection". H can der Schaar J Wilschut J Smit, Immunobiology 2009 214 613 626 10.1016/j.imbio.2008.11.008
12. "The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection". TC Pierson Q Xu S Nelson T Oliphant GE Nybakken DH Fremont MS Diamond, Cell Host Microbe 2007 1 135 145 10.1016/j.chom.2007.03.002 18005691
13. "Antibody-Dependent Enhancement of Virus Infection and Disease". SM Tirado KJ Yoon, Viral Immunology 2003 16 1 69 86 10.1089/088282403763635465 12725690
14. "Complement receptor mediates enhanced flavivirus replication in macrophages". MJ Cardosa JS Porterfield S Gordon, Journal of Experimental Medicine 1983 158 1 258 63 10.1084/jem.158.1.258 6864163
15. C Janeway P Travers M Walport M Shloochik, Immunobiology 9 19 http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=Fc&rid=imm.section. 1233#1234 7806259
16. "Monoclonal antibody-mediated enhancement of Dengue virus infection in vitro and in vivo and strategies for prevention". A Goncalvez R Engle M St Claire R Purcell C Lai, Proceedings from the National Academy of Sciences United States of America 2007 104 22 9422 9427 http://www.pnas.org/cgi/doi/10. 1073/pnas.0703498104 10.1073/pnas.0703498104 (Pubitemid 47185795)
17. "Cryo-EM reconstruction of Dengue virus in complex with the carbohydrate recognition domain of DC-SIGN". E Pokidysheva Y Zhang AJ Battisti CM Bator-Kelly PR Chipman C Xiao GG Gregorio WA Hendrickson RJ Kuhn MG Rossmann, Cell 2006 124 485 493 10.1016/j.cell.2005.11.042 16469696
18. "Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-mediated enhancement of Dengue virus infection is independent of DC-SIGN internalization signals". PY Lozach L Burleigh I Staropoli E Navarro-Sanchez J Harriague JL Virelizier FA Rey P Desprès F Arenzana-Seisdedos A Amara, Journal Biological Chemistry 2005 280 23698 23708 10.1074/jbc.M504337200 (Pubitemid 40884852)
19. "Immunopathological mechanisms in Dengue and Dengue hemorrhagic fever". S Green A Rothman, Current Opinion in Infectious Disease 2006 19 5 429 36 10.1097/01.qco.0000244047.31135.fa (Pubitemid 44338101)
20. "Role of Dendritic Cells in Antibody Dependent Enhancement of Dengue Virus Infection. K boonnak B Slike T Burgess R Mason S Wu P Sun K Porter I Rudinaman D Yuwono P Puthavathana M Marovich, Journal of Virology 2008 3939 3951 10.1128/JVI.02484-07 18272578
21. "Dengue virus infected dendritic cells trigger vascular leakage through metalloproteinase over production". N Luplerdlop D Misse D Bray V Deleuze JP Gonzalez V Leardkamolkarn H Yssel F Veas, EMBO Reports 2006 7 1176 1181 10.1038/sj.embor.7400814 17028575
22. "T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation". SE Henrickson TR Mempel IB Mazo B Liu MN Artyomov H Zheng A Peixoto MP Flynn B Senman T Junt HC Wong AK Chakraborty UH von Andrian, Nature Immunology 2008 9 3 282 91 10.1038/ni1559 18204450
23. "T-cell activation by dendritic cells in the lymph node: lessons from the movies". P Bousso, Nature Review 2008 8 675 684
24. "Differential Effects of Dengue Virus on Infected and Bystander Dendritic Cells". D Palmer P Sun C Celluzzi J Bisbing S Pang W Sun M Marovich T Burgess, Journal of Virology 2005 2432 2439 10.1128/JVI.79.4.2432- 2439.2005 15681444
25. "The Advent of the Cytokine Storm". I Clark, Immunology and Cell Biology 2007 85 271 273 10.1038/sj.icb.7100062 17551531
26. "Dengue Virus infected Dendritic cells trigger vascular leagage through metalloproteinase overproduction". N Luplertlop D Missé D Bray V Deleuze JP Gonzalez V Leardkamolkarn H Yssel F Veas, EMBO Reports 2006 7 11 1176 1181 10.1038/sj.embor.7400814 17028575
27. "Immunological mechanism in Dengue and Dengue hemorrhagic fever". S Green A Rothman, Current Opinion in Infectious Diseases 2006 19 429 436 10.1097/01.qco.0000244047.31135.fa 16940865
28. "Association Between Sex, Nutritional Status, Severity Of Dengue Hemorrhagic Fever, And Immune Status In Infants With Dengue Hemorrhagic Fever". TH Nguyen TL Nguyen HY Lei YS Lin BL Le KJ Huang CF Lin QH Do TQ Vu TM Lam TM Yeh JH Huang CC Liu SB Halstead, American Journal of Tropical Medicine and Hygiene 2005 72 4 370 374 15827272
29. "Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with Dengue & Dengue haemorrhagic fever during an outbreak". A Chakravarti R Kumaria, Indian Journal Medical Research 2006 123 1 11 4
30. "IL-10 levels in Dengue patients: Some findings from the exceptional epidemiological conditions in Cuba". AB Pérez G García B Sierra M Alvarez S Vzquez MV Cabrera R Rodríguez D Rosario E Martínez T Denny MG Guzmn, Journal of Medical Virology 2004 73 2 230 4 10.1002/jmv.20080 15122797
31. "Multiplex cytokine profile from Dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.". FA Bozza OG Cruz SM Zagne EL Azeredo RM Nogueira EF Assis PT Bozza CF Kubelka, BMC Infectious Disease 2008 8 86 10.1186/1471-2334-8-86
32. "Involvement of Oxidative Stress, NF-IL-6, and RANTES Expression in Dengue-2-Virus-Infected Human Liver Cells". YL Lin CC Liu JI Chuang HY Lei TM Yeh YS Lin YH Huang HS Liu, Virology 2008 276 1 114 126 10.1006/viro.2000. 0524
33. "Understanding the contribution of cellular immunity to Dengue disease pathogenesis". A Mathew A Rothman, Immunological Reviews 2008 225 300 313 10.1111/j.1600-065X.2008.00678.x 18837790
34. "Gamma interferon augments Fc-y receptor-mediated Dengue virus infection of human monocytic cells". U Kontny I Kurane FA Ennis, Journal of Virology 1988 62 3928 3933 2459406
35. "A protective role for Dengue virus-specific CD8+ T cells". LE Yauch RM Zellweger MF Kotturi A Qutubuddin J Sidney B Peters TR Prestwood A Sette S Shresta, Journal of Immunology 2009 182 8 4865 73 10.4049/jimmunol. 0801974
36. "Immunology and immunopathogenesis of Dengue disease". AL Rothman, Advanced Virus Research 2003 60 397 419 full-text
37. "Response of Nave and memory CD8+ T cells to antigen stimulation in vivo". H Veiga-Fernandes U Walter C Bourgeois A McLean B Rocha, Nature Immunology 2003 1 47 53 10.1038/76907
38. "Selective expansion of High or Low avidity Cytotoxic T lymphocytes and efficacy for adoptive immunotherapy". M Alexander-Miller G Leggat J Berzofsky, Proceedings of the National Academy of Science United States of America 1996 93 4102 4107 10.1073/pnas.93.9.4102 (Pubitemid 26144250)
39. "T cell responses in Dengue hemorrhagic fever: are cross-reactive T cells suboptimal?". J Mongkolsapaya T Duangchinda W Dejnirattisai S Vasanawathana P Avirutnan A Jairungsri N Khemnu N Tangthawornchaikul P Chotiyarnwong K Sae-Jang M Koch Y Jones A McMichael X Xu P Malasit G Screaton, Journal of Immunology 2006 176 6 3821 9
40. "Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human Cd4+ Cytotoxic T-Lymphocyte Clones". S Gagnon F Ennis A Rothman, Journal of Virology 1999 73 5 3623 3629 10196254
41. "Altered Cytokine Responses of Dengue-Specific CD4+ T cells to heterologous Serotypes". M Mangada A Rothman, The Journal of Immunology 2005 175 2676 2683 16081844
42. "Cross-Reactive Memory CD4+ T cells Alter the CD8+ T cell response to Heterologous Secondary Dengue Virus Infections in Mice in a Sequence Specific Manner". C Beaumier A Rothman, Viral Immunology 2009 22 3 215 219 10.1089/vim.2008.0089 19435418
43. "The Dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis". AK Falconar, Archives of Virology 1997 142 5 897 916 10.1007/s007050050127 9191856
44. Flaviviruses. TP Monath FX Heinz, Fields virology Lippincott-Raven, Philadelphia, Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, 1995 1 961 1034
45. "Endothelial cell apoptosis induced by antibodies against Dengue virus nonstructural protein 1 via production of nitric oxide". CF Lin HY Lei AL Shiau HS Liu TM Yeh SH Chen CC Liu SC Chiu YS Lin, Journal of Immunology 2002 169 2 657 64
46. "Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against Dengue virus nonstructural protein 1". CF Lin SC Chiu YL Hsiao SW Wan HY Lei AL Shiau HS Liu TM Yeh SH Chen CC Liu YS Lin, Journal of Immunology 2005 174 1 395 403
47. "Secreted NS1 of Dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E". P Avirutnan L Zhang N Punyadee A Manuyakorn C Puttikhunt W Kasinrerk P Malasit JP Atkinson MS Diamond, PLoS Pathogens 2007 3 11 183 10.1371/journal.ppat.0030183 18052531
48. "Vascular Leakage in Severe Dengue Virus Infections: A Potential Role for the nonstructural Viral Protein NS1 and Complement". P Avirutnan N Punyadee S Noisakran C Komoltri S Thiemmeca K Auethavornanan A Jairungsri R Kanlaya N Tangthawornchaikul C Puttikhunt SN Pattanakitsakul PT Yenchitsomanus J Mongkolsapaya W Kasinrerk N Sittisombut M Husmann M Blettner S Vasanawathana S Bhakdi P Malasit, Journal of infectious Disease 2006 193 8 1078 88 10.1086/500949
49. "Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition". M Basta, Molecular Immunology 2008 45 4073 4079 10.1016/j.molimm.2008.07.012 18706699
50. Immunobiology Section 2: the complement system and innate immunity. C Janeway P Travers M Walport M Shlomchick, http://www.ncbi.nlm.nih.gov/bookshelf/ br.fcgi?book=imm&part=A148#A161
51. "The alternative complement pathway revisited". M Harboe TE Mollnes, Journal of Cellular and Molecular Medicine 2008 12 4 1074 1084 10.1111/j.1582-4934.2008.00350.x 18419792
52. "The role of the anaphylatoxins in health and disease". A Klos AJ Tenner KO Johswich RR Ager ES Reis J Köhl, Molecular Immunology 2009 46 14 2753 66 10.1016/j.molimm.2009.04.027 19477527